A case of recalcitrant DRESS syndrome with multiple autoimmune sequelae treated with intravenous immunoglobulins

JAMA Dermatology

Volumn 149, Issue 4, 2013, Pages 494-495

  Singer, Elisha M ^b   Wanat, Karolyn A ^a   Rosenbach, Misha A ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; CREATININE; IMMUNOGLOBULIN; LAMOTRIGINE; METHYLPREDNISOLONE; PREDNISONE; THYROID PEROXIDASE ANTIBODY; THYROTROPIN;

ABNORMAL LABORATORY RESULT; ADULT; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ARTICLE; BIPOLAR DISORDER; CASE REPORT; CLINICAL FEATURE; COMPUTER ASSISTED TOMOGRAPHY; CREATININE BLOOD LEVEL; DRESS SYNDROME; DRUG DOSE INCREASE; EOSINOPHIL COUNT; FACE EDEMA; FAMILY HISTORY; FEMALE; FEVER; FOLLOW UP; HEART PALPITATION; HUMAN; HYPERGLYCEMIA; HYPERTHYROIDISM; HYPOTHYROIDISM; INSULIN DEPENDENT DIABETES MELLITUS; LEUKOCYTE COUNT; LYMPHADENOPATHY; LYMPHOCYTE COUNT; NAUSEA; PRIORITY JOURNAL; RASH; TREATMENT OUTCOME; VOMITING;

AUTOIMMUNE DISEASES; DRUG ERUPTIONS; EOSINOPHILIA; FEMALE; FOLLOW-UP STUDIES; HUMANS; IMMUNOGLOBULINS, INTRAVENOUS; IMMUNOLOGIC FACTORS; SYNDROME; YOUNG ADULT;

EID: 84876845833     PISSN: 21686068     EISSN: None     Source Type: Journal    
DOI: 10.1001/jamadermatol.2013.1949     Document Type: Article

References (10)

1. Kardaun SH, Sidoroff A, Valeyrie-Allanore L, et al. Variability in the clinical pattern of cutaneous side-effects of drugs with systemic symptoms: does a DRESS syndrome really exist? Br J Dermatol. 2007;156(3):609-611.
2. Brown RJ, Rother KI, Artman H, et al.Minocycline-induced drug hypersensitivity syndrome followed by multiple autoimmune sequelae. Arch Dermatol. 2009;145(1):63-66.
3. Cacoub P, Musette P, Descamps V, et al. The DRESS syndrome: a literature review. Am J Med. 2011;124(7):588-597.
4. Fields KS, PetersenMJ, Chiao E, Tristani-Firouzi P. Case reports: treatment of nevirapine-associated dress syndrome with intravenous immune globulin (IVIG). J Drugs Dermatol. 2005;4(4):510-513.
5. Joly P, Janela B, Tetart F, et al. Poor benefit/risk balance of intravenous immunoglobulins in DRESS. Arch Dermatol. 2012;148(4):543-544.
6. Hernandez-Bautista V, Yamazaki-Nakashimada MA, Vazquez-García R, Stamatelos-Albarrán D, Carrasco-Daza D, Rodríguez-Lozano AL. Treatment of Kimura disease with intravenous immunoglobulin. Pediatrics. 2011;128(6):e1633-e1635.
7. Orson FM. Intravenous immunoglobulin therapy suppresses manifestations of the angioedema with hypereosinophilia syndrome. Am J Med Sci. 2003;326(2):94-97. (Pubitemid 36993115)
8. Zhuang Q, Mazer B. Inhibition of IgE production in vitro by intact and fragmented intravenous immunoglobulin. J Allergy Clin Immunol. 2001;108(2):229-234. (Pubitemid 32735406)
9. Kano Y, Inaoka M, Sakuma K, Shiohara T. Virus reactivation and intravenous immunoglobulin (IVIG) therapy of drug-induced hypersensitivity syndrome. Toxicology. 2005;209(2):165-167. (Pubitemid 40568645)
10. French LE, Trent JT, Kerdel FA. Use of intravenous immunoglobulin in toxic epidermal necrolysis and Stevens-Johnson syndrome: our current understanding. Int Immunopharmacol. 2006;6(4):543-549.